We have isolated the mouse MyoD1 gene flanked by its promoter region by screening a genomic library with synthetic oligonucleotides. The structural gene is interrupted by two G + C rich introns. Transfection of the cloned gene inserted into an expression vector converts fibroblasts to myoblasts. Sequence analysis of about 650 bp of the 5' upstream region revealed the presence of several potential regulatory elements such as a TATA-box, an AP2-box, two SP1 -boxes and a CAAT-box. In addition, there are three half palindromic estrogen response elements, a potential cAMP response element and various muscle specific elements such as a muscle-specific CAAT-box (MCAT) and four potential binding sites for MyoD1. Using S1 protection analysis the major start site of transcription in muscle and myoblast cells was mapped 3 bp upstream of the published cDNA 5' end. Promoter activity of the 650 bp upstream fragment was tested by in vitro transcription and by transfection analysis of myoblasts and fibroblasts. In all promoter test systems used, MyoD1 promoter activity was detected in myoblasts as well as in fibroblasts. Furthermore, DNA methylation was found to turn off MyoD1 promoter activity both in myoblasts and in fibroblasts.
INTRODUCTION
Cellular differentiation is believed to be regulated by lineagespecific changes in gene transcription. In the case of muscle differentiation, activation of a family of transcriptional regulators (MyoDl, Myf-5, Myogenin and MRF4) is known to play a key role in both cellular determination and induction of musclespecific gene expression (for reviews see references [1] [2] [3] [4] [5] [6] . The ability of individual members of this myogenic family to convert upon transfection a variety of cell types irreversibly to the myogenic lineage suggests a very tight cell-type and tissue specific expression (7, 8) . The combined action of a mosaic of positive and negative regulatory factors might ultimately lead to a very restricted gene expression only in the muscle cell lineage. In addition, DNA methylation and the formation of inactive chromatin could influence the action of certain regulatory factors either in a specific (9) or in a more general manner (10) .
By far the best characterized member of the family of myogenic regulators is MyoDl. It was originally isolated from an embryonic fibroblast cell line, that upon treatment with the demethylating agent 5-azacytidine started to express MyoDl and therefore converted the fibroblasts into muscle cells (11) . MyoDl is a nuclear phosphoprotein (12) that interacts by means of its helix-loop-helix domain with other regulatory proteins in a functional (proteins E12, E47) (13, 14) or non-functional (protein Id) manner (15) . It binds either as homo-or as heterodimer to a specific sequence (CANNTG) (16) and is able to transactivate various skeletal-muscle specific genes (17) (18) (19) (20) (21) (22) including itself (23) as well as the other members of die myogenic family (24) . Furthermore, MyoDl gene expression is controlled by serum (25) , growth factors (26) , electrical activity (27) and by oncogenes such as ski (28) , fos and jun (29) , ras (29) and myc (30) ).
In order to study the positive and negative regulatory mechanisms involved in cell-type and tissue specific expression of one member of the myogenic regulatory family we have isolated the mouse MyoDl structural gene flanked by its promoter region. We have identified the position of two introns and the start site of transcription using SI mapping. We show by transfection into myoblasts and by in vitro transcription that a fragment of about 650 basepairs (bp) of the 5' upstream region contains a promoter with common regulatory elements. However, promoter activity is not strictly restricted to myoblasts indicating that additional sequences or DNA modification by methylation are needed for the cell-type and tissue specific expression. Indeed, using methylated promoter constructs we show both by transfection and by in vitro transcription, that DNA metylation has the potential to reduce or even block MyoDl promoter activity in both myoblasts and fibroblasts.
MATERIALS AND METHODS

Cloning and sequencing
A mouse genomic EMBL3 library (Clontech) was screened according to Maniatis et al. (31) by using a 70 bp oligonucleotide corresponding to the 5' end (pos. 150-220) of the published cDNA of MyoDl (7) . Sequence analysis was performed on both strands using the sequenase according to the protocols provided by the manufacturer (USB).
Plasmid constructions and DNA methylation
For transfection, promoter test vectors using a MyoDl-0-galactosidase fusion protein as indicator was constructed by replacing the Sphl/Kpnl fragment of pCHHO (Pharmacia) containing the SV40 promoter by a HindlH/StuI (pMOlO) or the Hindm/Taql (pMO22) fragment containing the MyoDl promoter region ( fig.l) . Linker oligonucleotides were inserted at the Stul/Kpnl and Taql/Kpnl junction in order to provide the correct reading frame.
For luciferase assays a promoter test vector was constructed by replacing the SV40 early promoter of pPALU (32) by a Hind m/BspMII fragment containing the MyoDl promoter ( fig.l) . Plasmids were methylated with CpG methylase (SssI, Biolabs) according to protocols provided by the manufacturer.
For in vitro transcription a vector was constructed (pMO50) by cloning the Hindm/Bsml fragment containing the MyoDl promoter region into Hindlll/Aflin sites of pUC18 ( fig.l ). An oligonucleotide of 42 bp containing cauliflower mosaic virus gene sequences was used as linker to join the Bsml/Afllll sites and to provide a unique sequence for primer extension.
A MyoDl expression vector was constructed by replacing a Stul/Aval fragment of pCHHO by a BspMII/Hindm fragment containing the MyoDl structural gene interrupted by two introns ( fig.l) .
SI mapping
Total RNA was isolated from tissues and cell culture by the guanidinium iso-thiocyanat method (33) . Single stranded DNA probe was labelled uniformly by primer extension, purified over an alkaline agarose gel and hybridized overnight at 55 °C with 30 fig of total RNA. The hybridisation mixture was then digested
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•1228 -1308 -1635 pMOtO with SI nuclease (Boehringer Mannheim) followed by phenol/chloroform extraction (34) . The resulting protected fragments were analysed on a 6% polyacrylamide/8 M urea sequencing gel.
In vitro transcription Skeletal muscle nuclear extracts from mouse hind limbs were prepared according to Zahradka et al. (35) and nuclear cell extracts from G-8 myoblasts and C3H/T101/2 fibroblasts were prepared according to Shapiro et al. (36) . In vitro transcription reactions were carried out in a 50 /tl volume, containing nuclear extracts (10 ^g protein) in 15 mM Hepes (pH 7.6), 30 mM KC1, 10 mM MgCl, 1 mM of each NTP, 12% glycerol, 2.5 mM DTT and 40 units RNAse inhibitor. Optimal transcription was obtained with 200 ng of closed circular template DNA. The reaction mixture was preincubated for 30 min at 30 °C before addition of ribonucleotides triphospates, followed by an additional incubation at 30°C for 30 min. The reaction mixture was treated with proteinase K, phenol/chloroform, and RNA was precipitated by ethanol. RNA was analysed by primer extension as described by Andrisiani et al. (37) . Cell culture and DNA transfection Mouse myoblasts (G-8) and fibroblasts (C3H/10T1/2) were both obtained from the American Type Culture Collection. Myoblasts were grown on collagen coated plates in Dulbecco's modified eagle's medium (DMEM) containing 4.5 g/1 glucose, 10% heat inactivated fetal calf serum (FCS) and 10% horse serum. Fibroblasts were grown in DMEM with 10% FCS. Transfection and promoter activity assay was basically performed according to Lucibello and Mueller (38) . Briefly, cells were plated in microtiter plates and grown for 20 to 24 hours to a confluency of about 60%. The cells were then transfected using 0 to 0.5 /ig plasmid DNA per well. DNA was dissolved in 100 )A serum free DMEM containing 1 p\ Lipofectin reagent (Gibco). Cells were cultured for 40 to 48 hours in the appropriate medium. /3-galactosidase assays were performed according to Lucibello and Mueller (38) . The difference in optical density OD4Q5-OD650 was measured by a microtiter plate reader. MyoDI-luciferase constructs were cotransfected with plasmid pCHHO as internal control and assayed according to de Wet et al. (39) . For staining, cells were fixed for 10 minutes in 100% methanol and stained with 10% Giemsa. (7) corresponding to the positions +790 to +1228 and +1308 to +1635 of our cloned gene ( fig.l) .
RESULTS
Cloning of the mouse MyoDI gene
The cloned MyoDI gene is functional
Sequence analysis of the MyoDI structural gene did not reveal any sequence difference to the published cDNA sequence (7) except for the presence of two introns. The sequence of the two introns and the joining exon is given in figure 2 . The 5' and 3' splice sites of both introns are in agreement with the so-called GT-AG rule for splice site selection (40) . The introns are 438 and 327 nucleotides long and contain 56 and 55% G+C respectively. Interestingly, both introns are rather poor in CpGs and therefore interrupt the CpG rich exons that have previously been defined as CpG island (41). 
a The significance of the various elements is discussed in the section result. ACE: myotube specific element found in the promoter of the acetylcholine receptor delta subunit (47) . b N stands for any nucleotide. In order to show that we have isolated a fully functional gene, a MyoDl expression vector that expresses the MyoDl structural gene under the control of the SV40 early promoter was constructed. The MyoDl expression vector was cotransfected with plasmid pRSV-neo into C3H/10T1/2 fibroblasts and after two days of incubation stable colonies were selected by addition of G418 (Gibco, 40 /tg/ml) to the culture medium. As indicated in figure 3 , growing the transfected cells for several days led to the formation of multinucleated myotubes indicating that fibroblasts had been converted into muscle cells.
Sequence analysis of the promoter region
The nucleotide sequence of the 5' upstream region and part of the first exon is shown in figure 4 . As compared to the MyoDl structural gene which is defined as a CpG island (41) its promoter region is rather poor in CpGs. Analysis of the 5' upstream sequence revealed several highly conserved elements typical for eukaryotic promoters transcribed by polymerase II (see fig. 4 and table 1) (42-44). A potential TATA-box is located at the unusual distance of 60 bp relative to the major start site of transcription. Various conserved upstream promoter elements for ubiquitous and skeletal-muscle specific factors are located upstream of the TATA-box. A consensus CAAT-box (42) is flanked by two GC-boxes (42) at an equal distance of 14 bp. Interestingly, the CAAT-box and both GC-boxes are in the inverse orientation. Just beside the CAAT-box there is a nearly conserved muscle specific CAAT-box (MCAT) (45) . Furthermore, an AP-2 binding site (46), a myotube specific element found also in the promoter of the acetylcholine receptor delta subunit (ACE) (47), three half palindromic estrogen response elements (ERE) (48) and four conserved binding sites for MyoDl and its relatives (16) can be identified. Not fully conserved, but known to be functional in other promoters is a potential cAMP response element (CRE) (49) , that could also represent a potential target for the negative regulation of MyoDl expression by the oncogene jun and fos (29) . The organisation of the regulatory elements of the MyoDl promoter is reminiscent of other eukaryotic promoters such as the Herpes simplex thymidine kinase promoter (50) , where the TATA box is also preceded by a CAAT-box flanked by two SP-1 boxes. Comparison of the MyoDl promoter sequence with the promoter sequence of other muscle-specific genes studied to date revealed a number of small regions of sequence homology (not shown). None of these, however, were present in more than one other muscle-specific gene promoter. Two pairs of direct repeats ( fig.4) can be found in the MyoDl promoter, but their potential significance, if any in terms of promoter function, remains to be determined.
Start site of the in vivo transcription of MyoDl
In order to determine the transcriptional start site and the celltype and tissue specific expression of the MyoDl gene, the SI nuclease protection assay was used. As shown in figure 5 and as reported by others (7), MyoDl transcripts can only be detected in RNA isolated from skeletal muscle and from G-8 myoblasts (lanes 3 and 6), but not from adult heart muscle, liver, spleen or C3H/10T1/2 fibroblasts (lanes 1,2,4,5). As seen in figure 5 the main protected band has a size of about 95 bp and therefore extends the previously published 5' cDNA end of MyoDl by 3 bp (7). Therefore transcription is initiated at one major start site both in fully differentiated, adult skeletal muscle cells and in G-8 myoblasts.
In vitro transcription of cloned MyoDl gene
The 5' upstream region of the MyoDl gene was tested for promoter activity by an in vitro transcription assay using nuclear extracts isolated from expressing (G-8 myoblasts and hind limb skeletal muscle cells) and non-expressing cells (C3H/10T1/2 fibroblasts). A plasmid was constructed (pMO50, fig.l) , that transcribes part of the 5' end of structural MyoDl gene fused to a unique sequence of cauliflower mosaic virus. Primer extension by an oligonucleotide complementary to the unique sequence allows the detection of the transcribed RNA. As shown in figure 6 a correct initiation of transcription when compared with the in vivo transcription was obtained by using nuclear extracts from G-8 myoblasts (lane 4) and hind limb skeletal muscle cells (lane 1). In addition, sensitivity of transcription to low concentrations of a-amanitin indicates that the MyoD 1 gene is transcribed by RNA polymerase II (lane 2).
By using nuclear extracts from C3H/10T1/2 fibroblasts (lane 3), we detect also specific transcriptional activity of plasmid pMO50. These results indicate that either cell-type specific regulatory factors or their DNA targets are missing in our cell free system, or that other mechanisms such as DNA methylation may play an important role in the cell type specific expression of MyoDl.
Promoter activity in transfected myoblasts and fibroblasts
The activity of the mouse MyoDl gene promoter was assayed by transient transfection of MyoDl-jS-galactosidase fusion constructs into G-8 myoblasts and C3H/10T1/2 fibroblasts. By using part of the first exon of MyoDl in our construct (pMOlO, fig.l) we include both translational efficiency and potential functional and structural effects associated with the CpG island on MyoDl promoter activity. Plasmid pMOlO transfected into G-8 myoblasts yielded about 10% of the activity detected with the SV40 early promoter of plasmid pCHl 10 (data not shown). A similar promoter activity was detected when deleting most of the first exon containing the MyoDl CpG island (plasmid pMO22 ( fig.l) data not shown). Therefore we conclude that there are no major positive regulatory elements in the MyoDl CpG island.
Interestingly, both plasmids (pMOlO, pMO22) were also active in fibroblasts where the endogenous gene is inactive. These results indicate that either our constructs have no fibroblast specific negative regulatory elements or that as already stated above DNA methylation may play a central role for the cell-type specific silencing of the MyoDl gene.
Inactivation of MyoDl promoter activity by CpG methylation
The ability of 5-azacytidine to reactivate a silent MyoDl gene (11) suggests, that DNA methylation may play a specific role in regulating MyoDl gene expression. In order to test the effect of methylation on the activity of our constructs a sensitive promoter test vector (pMO29, fig.l ) expressing the luciferase gene controlled by the MyoDl promoter was transfected into myoblasts and fibroblasts in the methylated and unmethylated form. Figure 8a shows that methylation of plasmid pMO29 by CpG methylase SssI resulted in a complete block of MyoDl promoter activity both in myoblasts and fibroblasts. By comparison, methylation of plasmid pPALU containing the SV40 early promoter reduced its activity to 15% and did not lead to a complete block of transcription (data not shown). It has been suggested (51) that the decrease of SV40 early promoter activity by DNA methylation is mainly a result of inactive chromation formation over the entire plasmid. When compared to the inhibition of the methylated SV40 promoter the complete block of MyoDl promoter activity indicates additional silencing mechanisms. MyoDl DNA methylation, therefore, may either prevent the binding of important activating factors or enhance the binding of a repressor(s) necessary for the silencing of the gene.
In contrast to the in vivo data, in vitro transcription with the same methylated DNA and muscle extracts resulted only in a 50% reduction of specific promoter activity (figure 8b). Similar results were obtained using nuclear extracts from C3H/T101/2 fibroblasts and G-8 myoblasts (data not shown). 1 ) were transfected into G-8 myoblasts and C3H/10T1/2 fibroblasts according to Lucibello and Mueller (38) . The difference in optical density OD^-OD^ was measured using a microtiter plate reader and corrected for cell-type specific background (38) . Each point represents the average of four different transfection series with a standard deviation below 15%. A control plasmid with the MyoDl promoter in the inverse orientation didn't show any promoter activity (data not shown). 
DISCUSSION
Using an oligonucleotide probe corresponding to the 5' end of the mouse MyoDl cDNA, we isolated genomic clones containing both the 5' upstream region and the full coding part of the mouse MyoDl gene interrupted by two introns. A conversion of fibroblasts into myoblasts was obtained by transfection of the coding part of MyoD 1 linked to the SV40 early promoter thus proving that we have isolated a fully functional MyoDl gene. We identify within 650 bp of the 5' flanking region various potential target sequences for ubiquitous and muscle specific factors. Among them is a potential cAMP response element that could also be the target for the previously reported inhibition of MyoDl gene expression by the oncogenes fos and jun (29) . In addition we find four consensus sequences for MyoDl (16) , which are possibly involved in autoregulation and regulation by other helix-loop-helix proteins. Using SI mapping we localize the major transcriptional start site of the MyoD 1 promoter 3 bp upstream of the previously published 5' end of the MyoDl cDNA (7) . We show by in vitro transcription and by transient transfection into myoblasts, that the 5' upstream region contains a functional promoter. The a-amanitin sensitivity of in vitro transcription and the organisation of several potential regulatory elements similar to other promoters (42) (43) (44) (45) (46) (47) indicate, that the MyoDl promoter is most likely transcribed by RNA polymerase n.
As indicated by the effects of various oncogenes (28-30), growth factors (26), serum (25) and electrical activity (27) , MyoD 1 gene expression in muscle cells is under multiple positive and negative control. Furthermore, regarding the dominant effect of the MyoDl protein in converting various cell lines to the myogenic lineage (7, 8) , a mechanism is expected to prevent any expression of MyoDl in non-muscle tissues. The experiments of Thayer and Weintraub on the silencing of the MyoDl gene in specific somatic cell fusions suggest the presence of specific repressor(s) in cells not expressing MyoDl (52) . In addition, the initiation of the myogenic program in fibroblasts treated with the demethylating agent 5-azacytidine (11) strongly suggests, that at least in fibroblasts DNA methylation plays a role in preventing MyoDl gene expression. Further experiments carried out by Lassar et al. have shown that the transfection of fibroblasts with total uncloned genomic DNA prepared from myoblasts (where MyoDl is not methylated), but not from fibroblasts (where MyoDl is methylated), was able to initiate the myogenic program (53) . More evidence for a direct role of DNA methylation in promoter inactivation comes from the observation that the immortalisation of primary fibroblasts and the complementary silencing of the MyoDl gene involved in terminal differentiation is correlated with the hypermethylation of the MyoDl associated CpG island (41) . We show here that for the inhibition of MyoDl promoter activity both in vivo and in vitro the MyoDl CpG island is not absolutely required. However, it is open whether the CpG island has at the chromosomal level a role in the formation of active or inactive chromatin or in the stabilisation of the methylated or unmethylated state at the MyoDl promoter (54) . It remains to be shown, whether DNA methylation inhibits the MyoD 1 promoter by preventing directly binding of positive acting factors (9) or indirectly by means of a methyl DNA binding protein (55) or the formation of inactive chromatin (10) . Recently the existence of such repressor proteins binding preferentially to methylated DNA has been described (55) (56) (57) (58) .
The isolation and identification of the MyoDl promoter is one step towards a more detailed characterisation of specific elements and mechanisms responsible for cell-type and tissue specific gene expression.
